Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study

BACKGROUND: Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Gavi, the Vaccine Alliance (Gavi). An economic evaluation of HPV vaccination is r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiendrébéogo, Joël Arthur, Sidibe, Annick Raissa O., Compaoré, Ghislain Bertrand, Nacanabo, Relwendé, Sory, Orokia, Ouédraogo, Issa, Nawaz, Saira, Schuind, Anne E, Clark, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693094/
https://www.ncbi.nlm.nih.gov/pubmed/38041075
http://dx.doi.org/10.1186/s12913-023-10283-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693094/
https://www.ncbi.nlm.nih.gov/pubmed/38041075
http://dx.doi.org/10.1186/s12913-023-10283-3

Ejemplares similares